GCG and diabetes mellitus: Another independent GLP‐1 agonist study, the ELIXA study, evaluated the effects of lixisenatide when compared to placebo in 6068 diabetes patients who had a history of myocardial infarction or hospitalization for unstable angina in the previous 180 days.